Clinical trial
Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating…
NCT00278629 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00278629 |
|---|---|
| Title | Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy |
| Official title | Non-myeloablative Autologous Hematopoietic Stem Cell Transplantation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Phase II Trial |
| Lead sponsor | Northwestern University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Inflammatory Demyelinating Polyneuropathy |
| Intervention type | Biological |
| Interventions | hematopoietic stem cell transplantation |
| Enrollment | 80 |
| Start date | Feb 21, 2005 |
| Primary completion | Jan 14, 2017 |
| Completion | Nov 4, 2019 |
| First posted | Jan 18, 2006 |
| Last update posted | Jul 23, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: